Pathstone Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Buy |
247,287
+30,634
| +14% | +$1.42M | 0.05% | 286 |
|
|
2025
Q1 | $13.2M | Buy |
216,653
+5,786
| +3% | +$353K | 0.06% | 249 |
|
|
2024
Q4 | $11.9M | Buy |
210,867
+21,917
| +12% | +$1.24M | 0.05% | 250 |
|
|
2024
Q3 | $9.78M | Buy |
188,950
+4,062
| +2% | +$210K | 0.04% | 326 |
|
|
2024
Q2 | $7.68M | Sell |
184,888
-28,081
| -13% | -$1.17M | 0.03% | 389 |
|
|
2024
Q1 | $11.5M | Sell |
212,969
-11,765
| -5% | -$638K | 0.05% | 264 |
|
|
2023
Q4 | $11.6M | Buy |
+224,734
| New | +$11.6M | 0.06% | 233 |
|